(Q34909942)

5 August 2017

1 reference

title

Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population (English)

1 reference

5 August 2017

1 reference

Ginés Sanz

1

1 reference

5 August 2017

Valentin Fuster

series ordinal

2

1 reference

5 August 2017

publication date

23 December 2008

1 reference

Nature Clinical Practice Cardiovascular Medicine

5 August 2017

published in

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

issue

2

1 reference

5 August 2017

page(s)

101-110

1 reference

Combination pharmacotherapy for cardiovascular disease

5 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNCPCARDIO1419

Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy

21 January 2018

1 reference

12 December 2020

Cardiovascular disease prevention with a multidrug regimen in the developing world: a cost-effectiveness analysis

1 reference

12 December 2020

WHO study on Prevention of REcurrences of Myocardial Infarction and StrokE (WHO-PREMISE)

1 reference

12 December 2020

Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications

1 reference

12 December 2020

Reduction in acute myocardial infarction mortality over a five-year period

1 reference

12 December 2020

MDGs: chronic diseases are not on the agenda

1 reference

12 December 2020

Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2).

1 reference

12 December 2020

Low priority of cardiovascular and chronic diseases on the global health agenda: a cause for concern

1 reference

12 December 2020

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

1 reference

12 December 2020

Angiotensin-Converting Enzyme Inhibitors in Patients With Coronary Artery Disease and Absence of Heart Failure or Left Ventricular Systolic Dysfunction

1 reference

12 December 2020

Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000

1 reference

12 December 2020

A strategy to reduce cardiovascular disease by more than 80%

1 reference

12 December 2020

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

12 December 2020

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

1 reference

12 December 2020

Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes

1 reference

12 December 2020

Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths

1 reference

12 December 2020

Benefits, challenges, and registerability of the polypill

1 reference

12 December 2020

Fixed-dose combinations improve medication compliance: a meta-analysis.

1 reference

12 December 2020

Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry

1 reference

12 December 2020

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Impact of fixed-dose combination drugs on adherence to prescription medications

1 reference

12 December 2020

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials

1 reference

12 December 2020

The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries

1 reference

12 December 2020

Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy

1 reference

12 December 2020

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

1 reference

12 December 2020

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

12 December 2020

Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005.

1 reference

12 December 2020

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study

1 reference

12 December 2020

Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

12 December 2020

Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes.

1 reference

12 December 2020

Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction

1 reference

12 December 2020

Highlights of the 2007 scientific sessions of the European Society of Cardiology Vienna, Austria, September 1-5, 2007

1 reference

12 December 2020

Impact of medication therapy discontinuation on mortality after myocardial infarction

1 reference

12 December 2020

Selected major risk factors and global and regional burden of disease

1 reference

12 December 2020

A polypill for secondary prevention: time to move from intellectual debate to action

1 reference

12 December 2020

Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies

1 reference

12 December 2020

Polypill holds promise for people with chronic disease

1 reference

12 December 2020

The polypill: at what price would it become cost effective?

1 reference

12 December 2020

Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

1 reference

12 December 2020

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

1 reference

12 December 2020

A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension

1 reference

12 December 2020

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

12 December 2020

Predictors of hospital mortality in the global registry of acute coronary events

1 reference

12 December 2020

Healthy lifestyle factors in the primary prevention of coronary heart disease among men: benefits among users and nonusers of lipid-lowering and antihypertensive medications

1 reference

12 December 2020

Identifiers

DOI

10.1038/NCPCARDIO1419

1 reference

Dimensions Publication ID

5 August 2017

1042138852

0 references

Fatcat ID

release_f7if3ufycbcspopc6yyiwia2bq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f7if3ufycbcspopc6yyiwia2bq

24 November 2022

mapped directly with Wikidata item

1 reference